Antibacterial Effect of Probiotic Yogurt Compared to Xylitol
Comparison of Antibacterial Effect of Probiotic Yogurt Against Xylitol-containing Chewing Gum on Salivary Streptococcus Mutans Count, Bacterial Adherence and Salivary pH in Geriatric Patients: A Randomized Controlled Trial
1 other identifier
interventional
96
0 countries
N/A
Brief Summary
This study will be conducted to evaluate the antibacterial effect of probiotic bacteria in yogurt in decreasing streptococcus mutans count in saliva and plaque, decreasing bacterial adherence and increasing salivary pH compared to xylitol-containing chewing gum after three months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2020
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2019
CompletedFirst Posted
Study publicly available on registry
March 25, 2019
CompletedStudy Start
First participant enrolled
June 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedMarch 26, 2019
March 1, 2019
3 months
March 16, 2019
March 22, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
streptococcus mutans count in saliva
The samples will be transported to the laboratory and cultured on selective media (dry Mitis Salivarius Agar with potassium tellurite medium and bacitracin) after serial dilutions. The plates will be incubated at 37ºC in 5-10% CO2 jar. then number of Colony Forming Units (CFU/ml) of Mutans Streptococci in saliva will be determined
3 months
Secondary Outcomes (3)
streptococcus mutans count in plaque
3 months
salivary pH
3 months
bacterial adherence
3 months
Study Arms (2)
xylitol chewing gum
ACTIVE COMPARATORXylitol is widely used as an added sweetener in sugar-free products. It has been found to prevent dental caries through reducing dental plaque and limiting salivary streptococcus mutans counts and their produced levels of lactic acid
probiotic yogurt
EXPERIMENTALProbiotics are live microorganisms that confer oral health benefits by adhering to the oral mucosa and surface of teeth as a part of the biofilm thus preventing the adhesion, colonization, and proliferation of cariogenic bacteria inhibiting the formation of pathogenic plaque
Interventions
Probiotics are found in different dairy products including yoghurt, that are known as carriers of probiotics. These products can be easily integrated in daily meals to reduce cariogenic streptococcus mutans bacteria in dental biofilm
Xylitol is widely used as an added sweetener in sugar-free products. It has been found to prevent dental caries through reducing dental plaque and limiting salivary streptococcus mutans counts and their produced levels of lactic acid
Eligibility Criteria
You may qualify if:
- Above 50 years old.
- Have sufficient cognitive ability to understand consent procedures.
- Males or Females.
- Co-operative patients.
- High caries risk patients (≥105 CFU for streptococcus mutans count)
You may not qualify if:
- Under antibiotic treatment
- Milk intolerant
- Consuming any other probiotic product
- Habitual consumers of xylitol products
- Use antibacterial mouthwash
- Lack of compliance
- Any systemic condition affecting salivary secretion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- 1. Allocation concealment: Operator H.M. will choose between numbers in an opaque sealed envelope, which will be arranged by D.K. who will not be involved in any of the phases of the clinical trial. Data will be recorded on a computer by H.M. and O.S. and all records of all patients will be kept with the main supervisor M.I. 2. Implementation: D.K. will generate the allocation sequence, enroll participants, and assign participants to interventions. 3. Blinding: The assessors M.A. and R.E. will be blinded to the material assignment.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Internal resident in conservative department
Study Record Dates
First Submitted
March 16, 2019
First Posted
March 25, 2019
Study Start
June 1, 2020
Primary Completion
September 1, 2020
Study Completion
December 1, 2020
Last Updated
March 26, 2019
Record last verified: 2019-03